IRIS

Anthracene

CASRN 120-12-7

IRIS Summary (PDF) (13 pp, 114 K)

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (13 pp, 114 K) Last Updated: 09/01/1990

System	RfD (mg/kg-day)	Basis	PoD	Composite UF	Confidence
Other	3 x 10^-1	No observed effects	NOEL : 1.000 x 10³ mg/kg-day	3000	Low

Reference Concentration for Inhalation Exposure (RfC) (PDF) (13 pp, 114 K)
Not assessed under the IRIS Program.

Cancer Assessment

Weight of Evidence for Cancer (PDF) (13 pp, 114 K) Last Updated: 01/01/1991

WOE Characterization	Framework for WOE Characterization
D (Not classifiable as to human carcinogenicity)	Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1986)

Basis:

Based on no human data and inadequate data from animal bioassays.
This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (13 pp, 114 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (13 pp, 114 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.